Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. - Wikidata - wikimedia - TriplyDB

Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment.

Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment.

http://www.wikidata.org/entity/Q35552600

about

Lupus nephritis: current update Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry.Missed opportunities for timely diagnosis of pediatric lupus in South Africa: a qualitative study.Epidemiology of Glomerular Disease in Southern Arizona: Review of 10-Year Renal Biopsy Data Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data.Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis Recent clinical trials in lupus nephritis.Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis.Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus.Colony-stimulating factor-1: a potential biomarker for lupus nephritis.A retrospective analysis of clinical presentation of lupus nephritis The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.Systemic lupus erythematosus in children and adolescents.Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis.Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation Prognostic factors in lupus nephritis.Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis Role of serum anti-C1q antibodies as a biomarker for nephritis activity in pediatric and adolescent Egyptian female patients with SLE Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis.Biomarkers of lupus nephritis determined by serial urine proteomics Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004.Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis.Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery Study Positive correlation of STAT1 and miR-146a with anemia in patients with systemic lupus erythematosus.Diagnosis and treatment of lupus nephritis flares--an update.Stem cell autograft and allograft in autoimmune diseases.Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis.Delays to care in pediatric lupus patients from the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.Update on Lupus Nephritis.Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response.Renal flare prediction and prognosis in lupus nephritis Hispanic patients.Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis.Renal biopsy at the onset of clinical lupus nephritis: can it yield useful information?Can measuring urinary biomarkers improve the management of lupus nephritis?Musculoskeletal and neuropsychiatric manifestations are the main source of persisting affection and organ damage in a German population of patients with systemic lupus erythematosus.An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.Antiproteinuric effect of angiotensin-converting enzyme inhibitors and an angiotensin II receptor blocker in patients with lupus nephritis.Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.Lupus nephritis in the Western Cape, a high prevalence area: an experience over three decades.

P2860

Q22000837-224C22C9-50E1-4E18-84D2-DB712F8DEEF7 Q28088753-A1FAF982-A862-4B46-9ED9-65D5383D75F0 Q30582614-A2B93244-EC89-4B9E-A5BB-77F668A6FCA1 Q30839806-F2337BCD-51A2-4EAC-A774-F6C63225A8E9 Q31091315-4EC7A75C-DD81-4160-985F-79670807DC2D Q31113750-C521CDC0-ABFF-448B-96D7-B933A2E7376A Q33785628-F3B88ACA-EB5B-49CE-835F-F59DAABE0276 Q33924437-B2BF0FFE-FCBC-4419-8B74-FF2B390F3B1F Q34082546-A97DB1DF-E369-462E-BEAD-BC9DFD22135F Q34187295-061B5ED8-6A15-48F7-8A94-353C70C5FA8C Q35027273-61AEC1C9-F91C-477D-9978-5D01606B8296 Q35223839-2238889C-0466-4F1F-948D-B4FB97B80F0E Q35533763-51F930A2-C99F-4BE2-820E-170ACB988CE8 Q35947491-080D4617-A57C-4164-9C87-758DDE31AB50 Q35971689-AE218627-0366-4EE4-95D8-554BD75D6F21 Q36020897-6119EB1B-F140-4022-9277-04B4CC6A9A51 Q36054839-1B646BB1-1A47-4DC6-A5A5-6E1522F66A2A Q36633311-8C75AD93-878D-4C8C-B2DF-4E72A56030FD Q36634902-67E4805D-C8D9-44BE-976F-E953BBC9AD13 Q36832462-4B0B0194-2BF2-4D5A-B1A7-C83D1C85D98E Q37038307-708DF25C-655B-4BF1-9CCA-BC79493719C7 Q37185798-28F1D846-A110-4AA7-A524-F43E783ED6BA Q37352584-6B62506B-7F91-488A-9395-0A7F39818E1D Q37541229-D733C1FA-FF14-428D-9EC5-EA050217600A Q37619622-529AB9FC-C8F1-45ED-81CB-59E18C2C0F61 Q38059445-5D66A186-E358-4FEB-A1BF-02A14E6620BF Q38287103-41136A2B-20B6-4A16-B5EB-30AA7C6C392C Q38446147-B7C6BB1F-9530-4C61-B195-F4C40F0217D7 Q38763655-931DB564-0A31-417E-8194-5EC31F23CF22 Q39002132-05AC94B0-D989-4662-B079-7B698E9620AF Q39454337-E699004B-A10E-41D1-8643-D270A9F97ACA Q41317916-3238B2B2-CC0C-40DE-8E31-B87110D4FEBD Q42233587-E5B11C76-0AAE-4649-9D66-B97A2EB00670 Q43107466-194E0F05-5550-4E26-9709-19DE70D6CDD9 Q43137630-D7EAC960-A176-4B9F-8C17-BBFF44502BB5 Q43716417-AD4C97EA-B5D7-4AF0-B679-42D87F7487FA Q44371554-BED122B7-8D95-449E-AE2F-72843BA23BB4 Q45934007-5BAFF763-3787-4541-A1E4-168ADC254AE1 Q46313788-7515A55F-A7E8-4E06-86E4-DAF1361BC7CA Q46390748-E8249336-8E1B-4B37-B739-062C9A66CB82

P2860

Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment.

http://www.wikidata.org/entity/Q35552600

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Improved clinical outcome of l ...... early diagnosis and treatment.

@ast

Improved clinical outcome of l ...... early diagnosis and treatment.

@en

type

label

Improved clinical outcome of l ...... early diagnosis and treatment.

@ast

Improved clinical outcome of l ...... early diagnosis and treatment.

@en

prefLabel

Improved clinical outcome of l ...... early diagnosis and treatment.

@ast

Improved clinical outcome of l ...... early diagnosis and treatment.

@en

P1433

Q35552600-2705C154-D7C1-46A6-A70D-E14BD0E310B8

P1476

Q35552600-2B45C8AC-BD5A-4AD7-A7A7-54E7FEC34FE9

P2093

Q35552600-0FDA1FDB-D998-4CFE-9BA9-E661DA5BE67B

Q35552600-2FF58EC4-1848-4D5E-9433-651B359C0FEC

Q35552600-47F3637D-63FC-4B04-BFB1-DF63575C8EBD

Q35552600-81F3E162-257F-47A4-A46E-C0F40FA5ECFE

Q35552600-B0D97CA1-760D-465C-8703-4BE8D43A7BE5

Q35552600-E380DFAB-29D3-4E8C-B058-632776BD4708

P2860

Q35552600-0E5A6F44-6F95-4CF6-BEB1-683BA3069EBE

Q35552600-35E481AD-E263-422A-B6F0-61A98EBB222E

Q35552600-39581B22-6A0F-43ED-B4D6-25C4041A567E

Q35552600-67440B10-5D21-4397-A8C8-073212F12126

Q35552600-72B42A2A-DA8D-4A0F-890B-9A11CF73E32E

Q35552600-8993FF01-B9D7-4EE7-AB36-BDF9B1857C67

Q35552600-9C4A04A0-CEE7-44DF-8C56-C38B27D09498

Q35552600-9D858032-71A3-4E23-9429-BB1AF04F8D09

Q35552600-BCB01CB1-648A-432C-80E3-7D21843CBC25

Q35552600-CB5C29D9-DD49-4C7F-A455-9D3EE64300C9

P304

Q35552600-D9F1B45B-1335-4BDE-BE54-46317C373F8E

P31

Q35552600-5226738C-E8EE-4700-9726-1CBE2C34B550

P356

Q35552600-1EA05A02-17DC-4B25-9FC6-D5D9CB979E04

P407

Q35552600-B52764C0-9A41-4B60-882C-1A90E93276EE

P433

Q35552600-D9DA1007-01FB-4A3D-9B55-BCD7BDC05BF0

P478

Q35552600-69812C11-8B5A-4D44-857F-64B027741B96

P577

Q35552600-DE23D8E3-C4D1-4CAA-9A53-C9D03D44F9B6

P5875

Q35552600-CA333913-3EB0-43BA-980F-D808B960FBB8

P698

Q35552600-FB342D28-7E45-4E9C-BA2C-EC525E56B8EF

P932

Q35552600-9E7CCA99-20E4-4054-8804-8CEE23346B37

P356

P1433

Annals of the Rheumatic Diseases

P1476

Improved clinical outcome of l ...... early diagnosis and treatment.

@en

P2093

Andrassy K

http://www.w3.org/2001/XMLSchema#string

Fiehn C

http://www.w3.org/2001/XMLSchema#string

Hajjar Y

http://www.w3.org/2001/XMLSchema#string

Ho AD

http://www.w3.org/2001/XMLSchema#string

Mueller K

http://www.w3.org/2001/XMLSchema#string

Waldherr R

http://www.w3.org/2001/XMLSchema#string

P2860

The 1982 revised criteria for the classification of systemic lupus erythematosus

Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation.

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus.

Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality.

Lupus nephritis.

Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Lupus nephritis: a retrospective review of 78 cases from a single center.

Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.

P304

435-439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.62.5.435

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10805264

http://www.w3.org/2001/XMLSchema#string

P698

12695156

http://www.w3.org/2001/XMLSchema#string

P932

1754523

http://www.w3.org/2001/XMLSchema#string